ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Aeterna Zentaris Announces Strategic Review and Engagement of Financial Advisor
March 13, 2019Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX: AEZS) announced today that its board of directors has formed a special committee of independent directors (the “Special Committee”) to review strategic options available to Aeterna Zentaris. -
Can a strategic review solve Mylan's problems? Don't count on it
August 10, 2018Mylan needs some serious help, and it's looking at its options—like selling off assets, or even the whole company—to keep shareholders happy. But it may not have that many options.
Pharma Sources Insight January 2025
